EditorialRaising the Dead: Mitochondrial Cardiolipin as a Key Target for Post-Cardiac Arrest Resuscitation, Ischaemia-Reperfusion Injury and Cardiomyopathy
Section snippets
Disclosures
Author has no financial conflict disclosures.
References (14)
- et al.
Distinct membrane properties are differentially influenced by cardiolipin content and acyl chain composition in biomimetic membranes
Biochim Biophys Acta
(2017) - et al.
Cardiolipin-targeted peptides rejuvenate mitochondrial function, remodel mitochondria, and promote tissue regeneration during aging
Arch Biochem Biophys
(2018) - et al.
Expert consensus document: Mitochondrial function as a therapeutic target in heart failure
Nat Rev Cardiol
(2017) - et al.
American Heart Association Council on basic cardiovascular sciences, council on clinical cardiology, and council on functional genomics and translational biology. mitochondrial function, biology, and role in disease: a scientific statement from the American Heart Association
Circ Res
(2016) - et al.
Increased survival time with SS-31 after prolonged cardiac arrest in rats
Heart Lung Circ
(2019) - et al.
Mitochondrial bioenergetics and cardiolipin alterations in myocardial ischemia-reperfusion injury: implications for pharmacological cardioprotection
Am J Physiol Heart Circ Physiol
(2018) - et al.
The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin
J Am Soc Nephrol
(2013)
There are more references available in the full text version of this article.
Cited by (2)
Targeting impaired bioenergetics in heart failure
2020, Clinical Bioenergetics: From Pathophysiology to Clinical TranslationMetabolomics Analysis of the Effect of Hydrogen-Rich Water on Myocardial Ischemia-Reperfusion Injury in Rats
2020, Journal of Bioenergetics and Biomembranes
© 2019 Published by Elsevier B.V. on behalf of Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ).